MaheshSeetharamMD

Oncology • Phoenix, AZ

Department Head of Sarcoma at Mayo Clinic Arizona

Join to view full profile

Dr. Seetharam is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Seetharam's full profile

Already have an account?

Office
5777 E Mayo Blvd
Phoenix, AZ 85054
Phone+1 480-342-2000

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 2007 - 2010
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2003 - 2007
Mysore Medical CollegeClass of 1998

Certifications & Licensure

CA State Medical License 2006 - Present
AZ State Medical License 2010 - 2026
NY State Medical License 2006 - 2008
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Study of Brentuximab Vedotin Combined With RCHOP or RCHP in Front-line Treatment of Patients With Diffuse Large B-cell Lymphoma (DLBCL) Start of enrollment: 2013 Aug 01
Terminated
Phase 2
Phase 3 Study to Treat Patients With Soft Tissue Sarcomas Start of enrollment: 2014 Jan 01
Completed
Phase 3
A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen Start of enrollment: 2014 Apr 09
Completed
Phase 3
A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC Start of enrollment: 2014 Mar 01
Completed
Phase 3
Study of TJ011133 in Participants With Relapsed/Refractory Advanced Solid Tumors and Lymphoma Start of enrollment: 2019 Apr 16
Completed
Phase 1
Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors Start of enrollment: 2020 Feb 13
Recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

A phase 2 study of a brachyury-targeting vaccine in combination with radiation therapy for the treatment of advanced chordoma.
Gregory M Cote, Anthony P Conley, Steven Attia, Brian A Van Tine, Mahesh Seetharam
Cancer. 2024-11-15
A Phase I Study of sequences of the CDK4/6 Inhibitor, Ribociclib Combined with Gemcitabine in Patients with Advanced Solid Tumors.
Mahesh Seetharam, Aurora Norman, Jacob Allred, Jianping Kong, Mateusz Opyrchal
Research Square. 2024-04-25
1 citations
Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort.
Oluwadunni E Emiloju, Jun Yin, Emily Koubek, Joel M Reid, Mitesh J Borad
Investigational New Drugs. 2024-02-01